论文部分内容阅读
一、前言眼底病为一重要致盲眼病,据广州地区1120例(1499眼)致盲原因分析,单眼盲741例因眼底病致盲者95眼,占12.84%,于白内障,眼外伤之后居第3位;双眼盲379例,因眼底病致盲29例,占3.82%居第6位。在致盲眼底病中,因视网膜中心静脉阻塞(CRVO)、糖尿病性视网膜病变、高血压性视网膜病变、视网膜静脉周围炎等出血性眼病而致盲者,也超过总例数半数以上。我科于1982~1983年底临床应用尿激酶治疗上述眼病所致眼底出血共
I. Introduction Ocular fundus is an important cause of blindness. According to the analysis of 1 120 cases (1499 eyes) in Guangzhou, there are 95 eyes with blindness in one eye, accounting for 12.84%. In cataract, 3 eyes; 379 cases of bilateral blindness, blindness due to fundus disease in 29 cases, accounting for 3.82% ranked 6th. In the blinding of fundus diseases, blindness caused by hemorrhagic eye diseases such as central retinal vein occlusion (CRVO), diabetic retinopathy, hypertensive retinopathy, and retinal peripheral venous inflammation also exceeded the total number of cases by more than half. I Division at the end of 1982 ~ 1983 clinical application of urokinase in the treatment of ocular fundus bleeding